Next, we evaluated FBXO11 levels in primary MDS CD34+ cells and found that they was strikingly reduced in MDS versus CD34+ cells from healthy individuals along with a concomitant decrease in NPM1 expression (Figure 6A). The gene discussed is CD34; the disease is myelodysplastic syndrome.